HOLX

NASDAQ · Health Care

Hologic Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks

$76.01

+0.36 (+0.48%)

As of May 10, 9:41 PM ET ·

Financial Highlights (FY 2026)

Revenue

4.02B

Net Income

554.94M

Gross Margin

56.3%

Profit Margin

13.8%

Rev Growth

-5.5%

D/E Ratio

0.50

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	56.3%	56.3%	59.4%	59.4%
Operating Margin	17.4%	15.7%	14.9%	18.1%
Profit Margin	13.8%	13.1%	12.4%	11.1%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	4.02B	4.26B	7.67B	6.30B
Gross Profit	2.27B	2.40B	4.56B	3.75B
Operating Income	700.72M	667.57M	1.14B	1.14B
Net Income	554.94M	528.68M	949.43M	701.56M
Gross Margin	56.3%	56.3%	59.4%	59.4%
Operating Margin	17.4%	15.7%	14.9%	18.1%
Profit Margin	13.8%	13.1%	12.4%	11.1%
Rev Growth	-5.5%	-5.5%	+12.8%	+4.3%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	2.83B	2.83B	3.22B	3.48B
Total Equity	5.66B	5.66B	8.23B	7.50B
D/E Ratio	0.50	0.50	0.39	0.46

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	721.71M	725.76M	1.84B	1.35B
Free Cash Flow	—	—	975.66M	594.87M